Gulf Acute Heart Failure Registry (GulfCARE)

This study has been completed.
Sponsor:
Collaborator:
Servier
Information provided by (Responsible Party):
Gulf Heart Association
ClinicalTrials.gov Identifier:
NCT01467973
First received: November 7, 2011
Last updated: April 20, 2014
Last verified: April 2014
  Purpose

The Gulf Heart Association (GHA) sponsored Gulf acute heart failure registry (Gulf CARE)is a multinational , multicentre, prospective, observational, hospital-based registry of patients with acute heart failure(AHF) with 3 month and one year follow-up.

Study Hypothesis: Due to variations in age at presentation, risk factors for heart failure particularly high prevalence of rheumatic heart disease in certain Gulf countries, variable medical practices and heart failure management setup in the Gulf region, AHF patients in the Gulf states are expected to have different presentation and receive different management than patients in European countries resulting in different outcome. It is also hypothesized that there is considerable gap between heart failure management guidelines and clinical practices in the Gulf region.


Condition
Acute Heart Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Gulf aCute heArt failuRe rEgistry (Gulf CARE)

Resource links provided by NLM:


Further study details as provided by Gulf Heart Association:

Primary Outcome Measures:
  • Study of acute heart failure in the Middle-East [ Time Frame: One year ] [ Designated as safety issue: No ]
    To describe the epidemiology, etiology, precipitating factors, demographics, clinical characteristics, management and outcome of patients admitted with acute heart failure in the Middle-East.


Secondary Outcome Measures:
  • To identify targets for the long term objectives of improving quality of care in acute heart failure patients from the Middle-East [ Time Frame: One year ] [ Designated as safety issue: No ]
    To identify targets for the long term objectives of improving quality of care, reducing morbidity and mortality and lowering the cost of managing patients with acute heart failure in the Middle-East


Enrollment: 5005
Study Start Date: February 2012
Study Completion Date: November 2013
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Detailed Description:

The Gulf Heart Association (GHA) initiated Gulf acute heart failure registry (Gulf CARE)is designed to assess epidemiology, clinical data, management and outcomes of AHF in six Gulf countries and whether published, professional guidelines on the diagnosis and treatment of heart failure are being applied appropriately in patients with heart failure. The registry will also provide a quantitative estimate as well as qualitative description of the hospital disease activity related to heart failure. The information gathered will identify management gaps in diagnosis and care of AHF patients that may be addressed by more effective implementation of current guidelines or development of AHF guidelines which may be appropriate to this region. Findings from this registry may help in knowing the current status of heart transplantation in the Middle-East countries as well as identify issues in establishing future heart transplant programme including selection of appropriate candidates and donors, requirements for pre- and post-transplant support.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients admitted to various hospitals in the Middle-East with acute heart failure.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of acute heart failure
  • Admitted to the participating hospitals

Exclusion Criteria:

  • Patients with acute heart failure who are discharged from the emergency room without admission.
  • Patients transferred from non-registry hospital
  • Failure to obtain informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01467973

Locations
Oman
Royal Hospital
Muscat, Oman, 111
Sponsors and Collaborators
Gulf Heart Association
Servier
Investigators
Principal Investigator: Kadhim J Sulaiman, FRCPI Royal Hospital, Muscat, Oman
Study Director: Prashanth Panduranga, FRCP(Edin) Royal Hospital
  More Information

Additional Information:
No publications provided

Responsible Party: Gulf Heart Association
ClinicalTrials.gov Identifier: NCT01467973     History of Changes
Other Study ID Numbers: GHA4
Study First Received: November 7, 2011
Last Updated: April 20, 2014
Health Authority: Qatar: Hamad Medical Corporation

Keywords provided by Gulf Heart Association:
Heart Failure
Heart Failure, Diastolic
Heart Failure, Systolic
Middle-East

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 23, 2014